biote (BTMD) director awarded 130,000 options and deferred RSUs
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
biote Corp. director Debra L. Morris reported compensation-related equity activity. She exercised derivative rights tied to Deferred Settlement RSUs into 21,407 shares of Class A Common Stock and now directly holds 71,562 common shares. She also received awards of 130,000 stock options with a $2.20 exercise price, expiring in 2036, and 39,036 Deferred Settlement RSUs that are fully vested but settle at future dates as described in the award terms.
Positive
- None.
Negative
- None.
Insider Trade Summary
21,407 shares exercised/converted
Mixed
4 txns
Insider
MORRIS DEBRA L
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Deferred Settlement RSU | 21,407 | $0.00 | -- |
| Grant/Award | Deferred Settlement RSU | 39,036 | $0.00 | -- |
| Grant/Award | Stock Option (Right to Buy) | 130,000 | $0.00 | -- |
| Exercise | Class A Common Stock | 21,407 | $0.00 | -- |
Holdings After Transaction:
Deferred Settlement RSU — 0 shares (Direct, null);
Stock Option (Right to Buy) — 130,000 shares (Direct, null);
Class A Common Stock — 71,562 shares (Direct, null)
Footnotes (1)
- Each Deferred Settlement RSU is the economic equivalent of one share of Issuer Class A Common Stock. The Deferred Settlement RSUs are fully vested upon grant, but settlement will be deferred until the earlier of calendar year 2026 or the date of the Reporting Person's separation from service. The Deferred Settlement RSUs are fully vested upon grant, but settlement will be deferred until the earlier of calendar year 2027 or the date of the Reporting Person's separation from service. All shares subject to the option award shall vest on the earlier of May 12, 2027 or the day prior to the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date.
Key Figures
RSU-derived shares acquired: 21,407 shares
Shares held after transactions: 71,562 shares
Stock options granted: 130,000 options
+3 more
6 metrics
RSU-derived shares acquired
21,407 shares
Class A Common Stock from Deferred Settlement RSU exercise on May 12, 2026
Shares held after transactions
71,562 shares
Direct holdings of Class A Common Stock after Form 4 transactions
Stock options granted
130,000 options
Right to buy Class A Common Stock, grant date May 12, 2026
Option exercise price
$2.20 per share
Strike price for 130,000 stock options
Option expiration
May 11, 2036
Expiration date of stock option award
Deferred Settlement RSUs granted
39,036 units
Fully vested RSUs economically equivalent to Class A Common Stock
Key Terms
Deferred Settlement RSU, Stock Option (Right to Buy), Exercise or conversion of derivative security, Class A Common Stock, +1 more
5 terms
Deferred Settlement RSU financial
"Each Deferred Settlement RSU is the economic equivalent of one share of Issuer Class A Common Stock."
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with an exercise price of 2.2000 per share."
Exercise or conversion of derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
Class A Common Stock financial
"security_title: Class A Common Stock"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
fully vested upon grant financial
"The Deferred Settlement RSUs are fully vested upon grant, but settlement will be deferred"
FAQ
What insider transactions did Debra L. Morris report at biote (BTMD)?
Debra L. Morris reported exercising derivative rights linked to Deferred Settlement RSUs into 21,407 shares of Class A Common Stock and receiving grants of 130,000 stock options and 39,036 Deferred Settlement RSUs. These are compensation-related awards, not open-market stock purchases or sales.
What are the terms of the 130,000 stock options granted to Debra L. Morris at biote?
Debra L. Morris received 130,000 stock options with a $2.20 exercise price, each option representing the right to buy one share of Class A Common Stock. The options expire on May 11, 2036, and vest based on continued service through the vesting date.
What are Deferred Settlement RSUs in the biote (BTMD) Form 4 filing?
Deferred Settlement RSUs are awards economically equivalent to one share of Class A Common Stock each. In this Form 4, 39,036 such RSUs were granted fully vested, but their settlement into shares is deferred to specified future calendar years or the reporting person’s separation from service.